Article Type
Article
Changed
Thu, 01/10/2019 - 12:15
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Author(s)
Lucky AW
Koltun W
Thiboutot D
Niknian M
Sampson-Landers C
Korner P
Marr J

Article PDF
082020143.pdf
Author and Disclosure Information

Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J

Issue
Cutis - 82(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
143-150
Sections
Original Research
Author(s)
Lucky AW
Koltun W
Thiboutot D
Niknian M
Sampson-Landers C
Korner P
Marr J
Author(s)
Lucky AW
Koltun W
Thiboutot D
Niknian M
Sampson-Landers C
Korner P
Marr J
Author and Disclosure Information

Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J

Author and Disclosure Information

Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J

Article PDF
082020143.pdf
Article PDF
082020143.pdf

Issue
Cutis - 82(2)
Issue
Cutis - 82(2)
Page Number
143-150
Page Number
143-150
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media